GLI Spearheads Initiative to Double the Five-Year Survival Rate by 2030
Washington, DC — The Global Liver Institute (GLI), along with 33 other leading health and medical organizations, has issued a global call-to-action to increase the five-year survival rate for liver cancer from 18% to 36% by 2030.
Liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. In the United States this year alone more than 42,000 people will be diagnosed with liver cancer and more than 31,000 people will die from this disease. The National Cancer Institute estimates that there were more than 83,000 people living with liver cancer in the United States in 2016.
To read the full press release click here.
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Adapting Cancer Treatment for Survivorship and Precision Care
November 7th 2024The American Journal of Managed Care® and Vanderbilt University Medical Center partnered on a recent Institute for Value-Based Medicine® event, which had the theme, “Bringing the Future to the Present in Cancer Care.”
Read More